Gritstone Bio Inc (GRTS)

0.8179 +0.03 (+3.87%) USD  |  NASDAQ  |  May 20, 16:00
0.8179 0.00 (0.00%) After-Hours: 05:21
More

Gritstone Bio Cash from Operations (Quarterly): -33.57M for March 31, 2024

Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2018. Upgrade now.
Date Value
March 31, 2024 -33.57M
December 31, 2023 -19.51M
September 30, 2023 -31.09M
June 30, 2023 -30.96M
March 31, 2023 -40.09M
December 31, 2022 -30.37M
September 30, 2022 -25.78M
June 30, 2022 -26.34M
March 31, 2022 -33.45M
December 31, 2021 -23.78M
September 30, 2021 -14.87M
June 30, 2021 -22.68M
March 31, 2021 10.65M
Date Value
December 31, 2020 -25.22M
September 30, 2020 -20.18M
June 30, 2020 -20.73M
March 31, 2020 -22.98M
December 31, 2019 -22.45M
September 30, 2019 -25.02M
June 30, 2019 -18.41M
March 31, 2019 -19.13M
December 31, 2018 -13.00M
September 30, 2018 1.90M
June 30, 2018 -12.01M
March 31, 2018 -15.06M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

-40.09M
Minimum
Mar 2023
10.65M
Maximum
Mar 2021
-23.84M
Average
-24.40M
Median

Cash from Operations (Quarterly) Benchmarks

Precision BioSciences Inc -18.98M
Humacyte Inc -27.35M
Verastem Inc -28.31M
BioVie Inc -5.852M
Adial Pharmaceuticals Inc -1.626M

Cash from Operations (Quarterly) Related Metrics

Cash from Investing (Quarterly) 12.30M
Cash from Financing (Quarterly) -0.379M
Free Cash Flow -118.27M
Free Cash Flow Per Share (Quarterly) -0.2847
Free Cash Flow to Equity (Quarterly) -33.90M
Free Cash Flow Yield -124.1%